Abstract:The incidence of metabolic disorders, such as obesity and type two diabetes (T2DM), continues to increase worldwide, and their onset is often attributed to adherence to a western diet and a sedentary lifestyle. However, large variability exists in one's likelihood of developing metabolic dysregulation, illustrating that our understanding of heritability patterns remains poorly understood. Diabetes and obesity are multifactorial diseases, and their onset is influenced by both genetic and environmental factors. Genome-wide association studies report a number of alterations in the coding sequence associated with the onset of T2DM and obesity. However, these genes explain only a fraction of the cases, leaving the majority unaccounted for. The missing heritability question implies that other factors are responsible for the onset and development of the disease. Given that the developing fetus is susceptible to the maternal environment, a growing body of evidence demonstrates that maternal metabolic characteristics as well as disruptions to the prenatal environment may induce long-term genetic, phenotypic, and physiologic adaptations in the developing fetus, which could have a permanent effect on its future health. This phenomenon is known as developmental programming and is mediated through epigenetic modifications, which include modulation of gene expressions that do not alter the original deoxyribonucleic (DNA) sequence. Epigenetic modifications are capable of changing gene expression in metabolism-related genes and are accomplished through DNA methylation, histone acetylation, and ribonucleic acid (RNA) mechanisms. In this review, we discuss maternal metabolic factors, such as obesity, dyslipidemia, and gestational diabetes (GDM) that lead to epigenetic changes in the offspring and predispose future generations to metabolic abnormalities. We will also describe the association between maternal lifestyle factors and exposure to toxins with epigenetic modulations in the offspring. Lastly, we will provide a brief review of the possibility of using epigenetics as potential interventions and therapeutic modalities to help in early diagnosis and prevention of metabolic disorders.

Molecular mechanisms involved in fetal programming and disease origin in adulthood

Epigenetics in neonatal diseases.

Long-term Outcomes and Potential Mechanisms of Offspring Exposed to Intrauterine Hyperglycemia

Fetal programming and lactation: modulating gene expression in response to undernutrition during intrauterine life

Epigenetic Programming and Fetal Metabolic Programming

Developmental programming of health and disease

Neurodevelopmental Programming of Adiposity: Contributions to Obesity Risk

Nutritional models of foetal programming and nutrigenomic and epigenomic dysregulations of fatty acid metabolism in the liver and heart

Maternal Diabetes and Fetal Programming Toward Neurological Diseases: Beyond Neural Tube Defects

Nutritional, pharmacological, and environmental programming of NAFLD in early life

Fetal programming of obesity and type 2 diabetes

Glucocorticoids and intrauterine programming of nonalcoholic fatty liver disease

Gestational Nutrition as a Predisposing Factor to Obesity Onset in Offspring: Role for Involvement of Epigenetic Mechanism

Prenatal programming of postnatal endocrine responses by glucocorticoids

Prenatal glucocorticoids and long-term programming

Aberrant DNA Methylation Mediates the Transgenerational Risk of Metabolic and Chronic Disease Due to Maternal Obesity and Overnutrition

Gestational Diabetes Mellitus, Programing and Epigenetics

Glucocorticoids, prenatal stress and the programming of disease

The fetal programming of food preferences: current clinical and experimental evidence

Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia

Maternal Metabolic Health, Lifestyle, and Environment - Understanding How Epigenetics Drives Future Offspring Health